The article outlines steps for conducting a health economic evaluation, comparing costs and benefits of different health technologies. It focuses on comparing new treatments with standard care using data from clinical trials. The main tool used is the incremental cost-effectiveness ratio (ICER), which shows the cost of gaining an additional unit of health when switching to a new technology. The goal is to help decision makers choose the most cost-effective option for treating diseases like rheumatic conditions.